Global Exelon Patch Market Growth 2025-2031

Global Exelon Patch Market Growth 2025-2031

Product Code:1483549

Published Date: Apr 16,2025

Pages: 125

Region: Global

Category: Medical Devices & Consumables

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US

The global Exelon Patch market size is predicted to grow from US$ 132 million in 2025 to US$ 203 million in 2031; it is expected to grow at a CAGR of 7.4% from 2025 to 2031.

Exelon Patch is a transdermal patch that delivers rivastigmine, a medication used to treat mild to moderate dementia associated with Alzheimer’s disease and Parkinson’s disease. It works by inhibiting acetylcholinesterase and butyrylcholinesterase, enzymes that break down acetylcholine, a neurotransmitter important for memory and cognition. By maintaining higher acetylcholine levels, Exelon Patch helps improve cognitive function and slow symptom progression. The patch provides a controlled, continuous release of medication over 24 hours, reducing gastrointestinal side effects compared to oral rivastigmine. It is applied once daily to clean, dry skin on the back, upper arm, or chest.

United States market for Exelon Patch is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Exelon Patch is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Exelon Patch is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Exelon Patch players cover Novartis, LTS Lohmann, Alvogen, Amneal Pharmaceuticals, Sandoz, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Exelon Patch Industry Forecast” looks at past sales and reviews total world Exelon Patch sales in 2024, providing a comprehensive analysis by region and market sector of projected Exelon Patch sales for 2025 through 2031. With Exelon Patch sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Exelon Patch industry.

This Insight Report provides a comprehensive analysis of the global Exelon Patch landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Exelon Patch portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Exelon Patch market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Exelon Patch and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Exelon Patch.

This report presents a comprehensive overview, market shares, and growth opportunities of Exelon Patch market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
    Low-dose Patch
    Medium-dose Patch
    High-dose Patch

Segmentation by Application:
    Hospital
    Clinic
    Other

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
    Novartis
    LTS Lohmann
    Alvogen
    Amneal Pharmaceuticals
    Sandoz
    Mylan
    Zydus Life
    ONO
    Luye Pharmaceutical
    Beijing Tide Pharmaceutical
    Jiangsu Kangbeide Pharmaceutical

Key Questions Addressed in this Report
What is the 10-year outlook for the global Exelon Patch market?
What factors are driving Exelon Patch market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Exelon Patch market opportunities vary by end market size?
How does Exelon Patch break out by Type, by Application?